Heron Therapeutics HRTX
NASDAQ HRTX
$0.31 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Heron Therapeutics (HRTX) Share-based Compensation (2010 - 2026)

Updated

Heron Therapeutics (HRTX) reported Share-based Compensation of $3.18 million for Q2 2026, up 13.6% from $2.8 million a year earlier and up 6.8% from the prior quarter.

Analysis

Heron Therapeutics (HRTX) Share-based Compensation (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Heron Therapeutics' Share-based Compensation came in at $11.19 million, up 8.3% year-over-year; for FY2025, it was $10.34 million, down 20.2% from FY2024.

  • Share-based Compensation has declined for six consecutive years, with a five-year compound annual growth rate of -27.1% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $12.96 million in FY2024 (-60.5%), $32.85 million in FY2023 (-23.6%), $42.98 million in FY2022 (-8.3%) and $46.85 million in FY2021 (-6.7%).
  • The Q2 2026 figure ranks as the highest quarterly Share-based Compensation since Q2 2024.
  • Year over year, Share-based Compensation gained in three of the last eight quarters, with an average decline of 17.3%.
  • The high point for year-over-year Share-based Compensation in five years was Q2 2023 (growth of 34.3%); the low point was Q2 2024 (a decline of 67.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.98 million (Q1 2026), $2.18 million (Q4 2025) and $2.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 458.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 166.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 231.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 170.20 Mn
10 Heron Therapeutics 58.85 Mn -130.71 Mn 26.09 Mn 3.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.18 Mn
Mar 31, 2026 2.98 Mn
Dec 31, 2025 2.18 Mn
Sep 30, 2025 2.85 Mn
Jun 30, 2025 2.80 Mn
Mar 31, 2025 2.51 Mn
Dec 31, 2024 2.30 Mn
Sep 30, 2024 2.72 Mn
Jun 30, 2024 4.57 Mn
Mar 31, 2024 3.38 Mn
Dec 31, 2023 4.32 Mn
Sep 30, 2023 6.68 Mn
Jun 30, 2023 13.90 Mn
Mar 31, 2023 7.95 Mn
Dec 31, 2022 10.51 Mn
Sep 30, 2022 11.20 Mn
Jun 30, 2022 10.35 Mn
Mar 31, 2022 10.92 Mn
Dec 31, 2021 12.89 Mn
Sep 30, 2021 11.24 Mn
API Access

Heron Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=HRTX&period=max&api_key=YOUR_API_KEY